Earnings Feed
Start Free
ANGIOTECH PHARMACEUTICALS INC·4

May 16, 6:04 PM ET

Neske Tammy 4

4 · ANGIOTECH PHARMACEUTICALS INC · Filed May 16, 2011

Insider Transaction Report

Form 4
Period: 2011-05-12
ANGIOTECH PHARMACEUTICALS INCANPI
Neske Tammy
SVP, Human Resources
Transactions
  • Other

    Common Stock

    2009-05-13$1.35/sh−5,500$7,425→ 0 total
  • Other

    Stock Option w/Tandem SAR

    2008-12-08−150,000→ 50,000 total
    Exercise: $0.21From: 2009-01-01Exp: 2013-12-07→ Common Stock (150,000 underlying)
  • Other

    Common Stock

    2009-08-14$1.90/sh−3,300$6,270→ 5,500 total
  • Other

    Common Stock

    2009-08-14$1.91/sh−3,000$5,730→ 8,800 total
  • Other

    Stock Option w/Tandem SAR

    2009-03-10−150,000→ 200,000 total
    Exercise: $0.38From: 2009-04-01Exp: 2014-03-09→ Common Stock (150,000 underlying)
  • Other

    Stock Option w/Tandem SAR

    2008-03-31−50,000→ 0 total
    Exercise: $8.90From: 2007-03-01Exp: 2012-02-04→ Common Stock (50,000 underlying)
  • Other

    Stock Option w/Tandem SAR

    2010-03-08−85,000→ 350,000 total
    Exercise: $1.09From: 2010-04-01Exp: 2015-03-07→ Common Stock (85,000 underlying)
Footnotes (2)
  • [F1]Effective May 12, 2011, all of the Company's existing common shares and options to acquire common shares were canceled without any payment or consideration therefor, in connection with the implementation of a plan of compromise or arrangement under the Companies' Creditors Arrangement Act (Canada).
  • [F2]Price in in Canadian $.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT